Pumactant

DB04955ExperimentalSmall molecule

Pumactant is a synthetic surfactant used for treating respiratory distress syndrome in neonates. It is a unique formulation of the naturally occurring phospholipids Dipalmitoylphosphatidycholine (DPPC) and Phosphatidyl Glycerol (PG).

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in asthma, lung injury, and surgical adhesions.Curator reviewed

Resolves to

What you can answer from here — as of April 02, 2025

3+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Pumactant, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account